| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
Description: structure in first source
Also Known As:| 1. | Neoplasms (Cancer)
06/01/2004
- "Bayer Corp, under license from Indena SpA, is developing BAY-59-8862, a taxane synthesized from 14beta-hydroxy-10-deacetylbaccatin III, for the potential treatment of cancer."
09/04/1997 - "Paclitaxel, docetaxel and a series of new analogs synthesized from 14beta-hydroxy-10-deacetylbaccatin III (14-OH-DAB), a natural diterpene closely related to the core synthon of the 2 above prototypes, were tested in vitro for their growth-inhibitory activity on different human cancer cell lines, including some expressing the classic multidrug-resistant (MDR) phenotype (MCF-7 ADRr and CEM VBLr)" Get all the results and reference details, order at left... |
| 1 Diseases and 2 more articles analyzed in the Research Interface, order at left... | |
| 1. | Paclitaxel (Taxol)
|
| 2. | IDN 5109 (BAY 59-8862)
|
| 3. | taxane
|
| 4. | docetaxel (Taxotere)
|
| 4 Drugs and Important Bio-Agents and 2 more articles analyzed in the Research Interface, order at left... | |
| Price: | $490.00 access via web interface, 1 year subscription |
| Price: | $45.00 access via "curehunter.com/m", 1 year subscription |